The funds backing longevity in Singapore and Australia.

The capital backing longevity in Singapore and Australia, sourced and dated. Filter by market or type to find who is funding what.

Market

18 of 18 funds

Australia

AirTree Ventures

Led Everlab's AU$65M Series A (Jun 2026).

Australia

AustralianSuper

Super-fund LP in domestic venture.

Australia

Aware Super

Super-fund LP in domestic venture.

Australia

Blackbird Ventures

Largest AU venture platform; health/bio exposure across portfolio.

Australia

Brandon Capital

ANZ's largest life-sciences VC; latest fund BB6 ~A$439M.

Singapore

EDBI

Cell/gene therapy, genomics, precision medicine.

Australia

Future Fund

Australia's sovereign wealth fund.

Singapore

Heliconia Capital

Subsidiary of Temasek-backed 65 Equity Partners; SME growth capital.

Australia

HESTA

Health-sector super fund; venture LP.

Australia

Hostplus

Australia's most active super-fund VC LP.

Australia

Main Sequence

CSIRO venture arm; deep-tech and health.

Australia

Medical Research Future Fund

Commonwealth medical-research endowment.

Australia

OneVentures

Life-sciences and healthcare specialist VC.

Singapore

SGInnovate

Deep-tech venture builder.

Australia

Square Peg Capital

Major AU/IL venture platform.

Singapore

Temasek

Parent of Vertex Holdings; Insilico IPO cornerstone.

Australia

Tenmile

Tattarang/Forrest health fund, explicitly longevity-adjacent.

Singapore

Vertex Holdings

Temasek venture platform.